Testosterone Enanthate: Adjunctive Therapy for Myasthenia Gravis in American Males
Reading Time: 2 minutes Introduction Myasthenia gravis (MG) remains a formidable autoimmune neuromuscular disorder, disproportionately impacting muscle strength and quality of life, particularly among American males where incidence rates have risen steadily. According to the National Institute of Neurological Disorders and Stroke (NINDS), MG affects approximately 20 per 100,000 individuals in the United States, with males over 50 exhibiting heightened vulnerability due to age-related thymic involution and hormonal shifts. Testosterone enanthate (TE), a long-acting intramuscular androgen ester, has emerged as a potential adjunctive therapy. This article synthesizes emerging neurological research, elucidating TE's immunomodulatory effects on MG pathophysiology, symptom attenuation, and long-term outcomes tailored to...


